Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response
Active, not recruitingOBSERVATIONAL
Enrollment
28
Participants
Timeline
Start Date
August 20, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2031
Conditions
Prostate CarcinomaLocalized Prostate AdenocarcinomaStereotactic Body RadiotherapyStereotactic RadiotherapyMagnetic Resonance ImagingMultiparametric MRI
Trial Locations (1)
8091
University Hospital Zurich, Zurich
All Listed Sponsors
lead
University of Zurich
OTHER
NCT06822491 - Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response | Biotech Hunter | Biotech Hunter